In order to ensure a smooth development and clinical process, companies must carefully plan their activities with regard to the innovator biopharmaceutical.
This BIOVIA customer uniquely combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility associated with the world of biotech. The company focuses on a range of illnesses including cancer, cardiovascular disease, diabetes, hepatitis B, HIV/ AIDS, rheumatoid arthritis and psychiatric disorders. Their R&D organization prioritizes pipeline velocity and sales growth while continuing to manage costs.
This white paper explores best practices in SaaS selection and incorporation into laboratory practices that enable organizations to focus on their core competencies while utilizing best-of-breed software.
Formulation techniques and technologies can easily become more habit than science, but a single technology does not work for all compounds. Each new drug is unique and deserves a fresh approach to formulation.
Flu vaccine production – tracking and optimizing yield throughout the development and manufacturing process.
Continued Process Verification (CPV), Process Analytical Technology (PAT) and Quality by Design (QbD), are driving pharma to improve product and process quality and efficiency.
This study focusses on the use of Vivaflow® 200 crossflow cassettes to concentrate up to 3 L clear murine hybridoma supernatant 10-fold prior to affinity chromatography.
The yeast 2-hybrid system (Y2H) is a powerful screening technique that is readily adaptable to high throughput screening on the iQue.
SidePlate is pleased to announce the launch of its new website and integrated client portal. The goal of this redesign is to improve the availability, functionality and ease-of-use of SidePlate’s customer experience platform